John Moore Vierling, M.D., professor of medicine and of Surgery, chief of Hepatology, director of Baylor Liver Health at Baylor College of Medicine and director of Advanced Liver Therapies at Baylor St. Luke’s Medical Center, was honored to deliver the 24th Annual Leon Schiff Lectureship at the Miller School of Medicine at the University of Miami on Feb. 7, 2018. Dr. Vierling presented, “Primary Sclerosing Cholangitis: An Update for Clinicians”.
Dr. Leon Schiff’s career had a great impact, as he was a consummate clinician, researcher, educator, administrator and author of the classic textbook Schiff’s Diseases of the Liver currently in its 12th edition.
Dr. Vierling and Leon Schiff’s son, Dr. Eugene Schiff are both past presidents of the American Association for the Study of Liver Diseases (AASLD), Leon Schiff was one of AASLD’s founders and served as its first president in 1950.
Dr. Vierling is board certified in internal medicine and gastroenterology and a fellow of the American College of Physicians. Dr. Vierling’s basic science laboratory investigations have used murine models to study the immunopathogenesis of non-suppurative destructive cholangitis, which destroys bile ducts in primary biliary cirrhosis, an autoimmune liver disease, as well as in two alloimmune diseases, hepatic allograft rejection and chronic graft-versus-host disease.
Dr. Vierling is the author of numerous research publications. Dr. Vierling has also been active in the design and execution of clinical therapeutic trials of antiviral agents for treatment of hepatitis B and C infections in patients before and after liver transplantation, and trials of immunosuppressive drugs in liver transplantation and autoimmune liver diseases.